Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in the Frontline Treatment of Older AML Patients Unfit for Intensive Chemotherapy, in Blood Advances 14 February 2019
Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care 31 January 2019
Wound Care: new clinical data show Nexodyn® AOS To reduce reinfections and healing time in diabetic foot ulcers 31 January 2019
Ebola: Promising Early-Stage Safety Clinical Trial Results For Potential Treatment Based On Antibodies Isolated In Switzerland 25 January 2019
Linkedin